Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002033916-25-000010
Filing Date
2025-02-10
Accepted
2025-02-10 17:22:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8386
  Complete submission text file 0002033916-25-000010.txt   10248
Mailing Address 290 HARBOR DR 3RD FLOOR STAMFORD CT 06902
Business Address 290 HARBOR DR 3RD FLOOR STAMFORD CT 06902 475-900-9550
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

EIN.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Subject) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94325 | Film No.: 25606738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)